Masanori Okaniwa

Masanori Okaniwa is a seasoned professional in oncology clinical development, currently serving as Global Program Leader and Senior Director at Takeda Oncology since August 2016. With a focus on drug development initiatives, Okaniwa has held multiple leadership roles, including Director of Immuno-Oncology Research and Director of Special Projects. Previous experience includes positions at Takeda Pharmaceutical Company Ltd as Associate Director of Medicinal Chemistry and Principal Scientist in drug discovery for inflammation, as well as a postdoctoral fellowship at the University of California, San Francisco, where a novel therapeutic agent for mTOR resistant tumors was discovered. Okaniwa holds a Ph.D. in Medicinal and Pharmaceutical Sciences from Kyoto Pharmaceutical University and additional academic credentials in organic chemistry and pharmaceutical sciences.